China NMPA Drug Inspection - Hainan Sanye Pharmaceutical Factory Co., Ltd. - Compound Glycyrrhiza Tablets
China NMPA drug inspection for Hainan Sanye Pharmaceutical Factory Co., Ltd. published March 18, 2008. Drug: Compound Glycyrrhiza Tablets. The State Food and Drug Administration (SFDA) of China issued its 4th National Drug Quality Bulletin of 2007 on March 18
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Hainan Sanye Pharmaceutical Factory Co., Ltd. published March 18, 2008. Drug: Compound Glycyrrhiza Tablets. The State Food and Drug Administration (SFDA) of China issued its 4th National Drug Quality Bulletin of 2007 on March 18
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox